Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 3
1975 2
1977 3
1978 2
1979 3
1980 1
1981 2
1982 4
1983 2
1984 5
1985 7
1986 4
1987 6
1988 7
1989 7
1990 4
1991 3
1992 3
1993 5
1994 4
1995 5
1996 6
1997 7
1998 5
1999 10
2000 10
2001 13
2002 14
2003 17
2004 25
2005 24
2006 29
2007 48
2008 86
2009 86
2010 89
2011 97
2012 113
2013 139
2014 198
2015 207
2016 218
2017 213
2018 256
2019 314
2020 324
2021 380
2022 424
2023 409
2024 475
2025 513
2026 163
2027 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,442 results

Results by year

Filters applied: . Clear all
Page 1
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial.
Qi C, Liu C, Peng Z, Zhang Y, Wei J, Qiu W, Zhang X, Pan H, Niu Z, Qiu M, Qin Y, Fang W, Ye F, Li N, Liu T, Liu A, Zhang X, Hu C, Zhang J, Cui J, Lin X, Wang S, Zhang J, Lin T, Qu X, Yuan X, Gong J, Li J, Gao W, Gai L, Wang Y, Yuan D, Li Z, Shen L. Qi C, et al. Among authors: yuan d. Lancet. 2025 Jun 7;405(10494):2049-2060. doi: 10.1016/S0140-6736(25)00860-8. Epub 2025 May 31. Lancet. 2025. PMID: 40460847 Clinical Trial.
METTL3 mediates atheroprone flow-induced glycolysis in endothelial cells.
Zhao GJ, Han SY, Li Y, Yuan D, Qin S, Li Y, Jang H, Chen LJ, Wei TW, He M, Li YS, Bouman Chen Z, Shi L, Chien S, Shyy JY. Zhao GJ, et al. Among authors: yuan d. Proc Natl Acad Sci U S A. 2025 May 13;122(19):e2424796122. doi: 10.1073/pnas.2424796122. Epub 2025 May 6. Proc Natl Acad Sci U S A. 2025. PMID: 40327688 Free PMC article.
Ultrasensitive detection and tracking of circulating tumor DNA to predict relapse and survival in patients with locally advanced cervical cancer: phase III CALLA trial analyses.
Mayadev J, Vázquez Limón JC, Ramírez Godinez FJ, Leiva M, Cetina-Pérez LDC, Varga S, Molina Alavez A, Alarcon-Rozas AE, Valdiviezo N, Acevedo C, Figueroa A, Santini A, Vera L, Rey F, Kahán Z, Galaz P, Meléndez Mier G, Wu X, Mandai M, Shapira-Frommer R, Estevez-Diz MDP, Limaye S, Xin W, Dry H, Broggi MAS, Yuan DY, Stewart RA, Monk BJ. Mayadev J, et al. Among authors: yuan dy. Ann Oncol. 2025 Sep;36(9):1047-1057. doi: 10.1016/j.annonc.2025.05.533. Epub 2025 Jun 2. Ann Oncol. 2025. PMID: 40500687 Free article. Clinical Trial.
4,442 results